Discovery of antibiotic (E)-3-(3-carboxyphenyl)-2-(4-cyanostyryl)quinazolin-4(3 H)-one

Renee Bouley; Malika Kumarasiri; Zhihong Peng; Lisandro H. Otero; Wei Song; Mark A. Suckow; Valerie A. Schroeder; William R. Wolter; Elena Lastochkin; Nuno T. Antunes; Hualiang Pi; Sergei Vakulenko; Juan A. Hermoso; Mayland Chang; Shahriar Mobashery

doi:10.1021/jacs.5b00056

Discovery of antibiotic (E)-3-(3-carboxyphenyl)-2-(4-cyanostyryl)quinazolin-4(3 H)-one

Renee Bouley, Malika Kumarasiri, Zhihong Peng, Lisandro H. Otero, Wei Song, Mark A. Suckow, Valerie A. Schroeder, William R. Wolter, Elena Lastochkin, Nuno T. Antunes, Hualiang Pi, Sergei Vakulenko, Juan A. Hermoso, Mayland Chang, Shahriar Mobashery

Research output: Contribution to journal › Article › peer-review

119 Scopus citations

Abstract

In the face of the clinical challenge posed by resistant bacteria, the present needs for novel classes of antibiotics are genuine. In silico docking and screening, followed by chemical synthesis of a library of quinazolinones, led to the discovery of (E)-3-(3-carboxyphenyl)-2-(4-cyanostyryl)quinazolin-4(3H)-one (compound 2) as an antibiotic effective in vivo against methicillin-resistant Staphylococcus aureus (MRSA). This antibiotic impairs cell-wall biosynthesis as documented by functional assays, showing binding of 2 to penicillin-binding protein (PBP) 2a. We document that the antibiotic also inhibits PBP1 of S. aureus, indicating a broad targeting of structurally similar PBPs by this antibiotic. This class of antibiotics holds promise in fighting MRSA infections.

Original language	English
Pages (from-to)	1738-1741
Number of pages	4
Journal	Journal of the American Chemical Society
Volume	137
Issue number	5
DOIs	https://doi.org/10.1021/jacs.5b00056
State	Published - Feb 11 2015

Bibliographical note

Publisher Copyright:
© 2015 American Chemical Society.

Funding

Funders	Funder number
National Institutes of Health (NIH)
National Institute of General Medical Sciences	T32GM075762

ASJC Scopus subject areas

Catalysis
General Chemistry
Biochemistry
Colloid and Surface Chemistry

Access to Document

10.1021/jacs.5b00056

Cite this

Bouley, R., Kumarasiri, M., Peng, Z., Otero, L. H., Song, W., Suckow, M. A., Schroeder, V. A., Wolter, W. R., Lastochkin, E., Antunes, N. T., Pi, H., Vakulenko, S., Hermoso, J. A., Chang, M., & Mobashery, S. (2015). Discovery of antibiotic (E)-3-(3-carboxyphenyl)-2-(4-cyanostyryl)quinazolin-4(3 H)-one. Journal of the American Chemical Society, 137(5), 1738-1741. https://doi.org/10.1021/jacs.5b00056

@article{bfd7815cb78944f2b500caafba1f52be,

title = "Discovery of antibiotic (E)-3-(3-carboxyphenyl)-2-(4-cyanostyryl)quinazolin-4(3 H)-one",

abstract = "In the face of the clinical challenge posed by resistant bacteria, the present needs for novel classes of antibiotics are genuine. In silico docking and screening, followed by chemical synthesis of a library of quinazolinones, led to the discovery of (E)-3-(3-carboxyphenyl)-2-(4-cyanostyryl)quinazolin-4(3H)-one (compound 2) as an antibiotic effective in vivo against methicillin-resistant Staphylococcus aureus (MRSA). This antibiotic impairs cell-wall biosynthesis as documented by functional assays, showing binding of 2 to penicillin-binding protein (PBP) 2a. We document that the antibiotic also inhibits PBP1 of S. aureus, indicating a broad targeting of structurally similar PBPs by this antibiotic. This class of antibiotics holds promise in fighting MRSA infections.",

author = "Renee Bouley and Malika Kumarasiri and Zhihong Peng and Otero, {Lisandro H.} and Wei Song and Suckow, {Mark A.} and Schroeder, {Valerie A.} and Wolter, {William R.} and Elena Lastochkin and Antunes, {Nuno T.} and Hualiang Pi and Sergei Vakulenko and Hermoso, {Juan A.} and Mayland Chang and Shahriar Mobashery",

note = "Publisher Copyright: {\textcopyright} 2015 American Chemical Society.",

year = "2015",

month = feb,

day = "11",

doi = "10.1021/jacs.5b00056",

language = "English",

volume = "137",

pages = "1738--1741",

number = "5",

}

Bouley, R, Kumarasiri, M, Peng, Z, Otero, LH, Song, W, Suckow, MA, Schroeder, VA, Wolter, WR, Lastochkin, E, Antunes, NT, Pi, H, Vakulenko, S, Hermoso, JA, Chang, M & Mobashery, S 2015, 'Discovery of antibiotic (E)-3-(3-carboxyphenyl)-2-(4-cyanostyryl)quinazolin-4(3 H)-one', Journal of the American Chemical Society, vol. 137, no. 5, pp. 1738-1741. https://doi.org/10.1021/jacs.5b00056

TY - JOUR

T1 - Discovery of antibiotic (E)-3-(3-carboxyphenyl)-2-(4-cyanostyryl)quinazolin-4(3 H)-one

AU - Bouley, Renee

AU - Kumarasiri, Malika

AU - Peng, Zhihong

AU - Otero, Lisandro H.

AU - Song, Wei

AU - Suckow, Mark A.

AU - Schroeder, Valerie A.

AU - Wolter, William R.

AU - Lastochkin, Elena

AU - Antunes, Nuno T.

AU - Pi, Hualiang

AU - Vakulenko, Sergei

AU - Hermoso, Juan A.

AU - Chang, Mayland

AU - Mobashery, Shahriar

PY - 2015/2/11

Y1 - 2015/2/11

N2 - In the face of the clinical challenge posed by resistant bacteria, the present needs for novel classes of antibiotics are genuine. In silico docking and screening, followed by chemical synthesis of a library of quinazolinones, led to the discovery of (E)-3-(3-carboxyphenyl)-2-(4-cyanostyryl)quinazolin-4(3H)-one (compound 2) as an antibiotic effective in vivo against methicillin-resistant Staphylococcus aureus (MRSA). This antibiotic impairs cell-wall biosynthesis as documented by functional assays, showing binding of 2 to penicillin-binding protein (PBP) 2a. We document that the antibiotic also inhibits PBP1 of S. aureus, indicating a broad targeting of structurally similar PBPs by this antibiotic. This class of antibiotics holds promise in fighting MRSA infections.

AB - In the face of the clinical challenge posed by resistant bacteria, the present needs for novel classes of antibiotics are genuine. In silico docking and screening, followed by chemical synthesis of a library of quinazolinones, led to the discovery of (E)-3-(3-carboxyphenyl)-2-(4-cyanostyryl)quinazolin-4(3H)-one (compound 2) as an antibiotic effective in vivo against methicillin-resistant Staphylococcus aureus (MRSA). This antibiotic impairs cell-wall biosynthesis as documented by functional assays, showing binding of 2 to penicillin-binding protein (PBP) 2a. We document that the antibiotic also inhibits PBP1 of S. aureus, indicating a broad targeting of structurally similar PBPs by this antibiotic. This class of antibiotics holds promise in fighting MRSA infections.

UR - http://www.scopus.com/inward/record.url?scp=84922762182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922762182&partnerID=8YFLogxK

U2 - 10.1021/jacs.5b00056

DO - 10.1021/jacs.5b00056

M3 - Article

C2 - 25629446

AN - SCOPUS:84922762182

SN - 0002-7863

VL - 137

SP - 1738

EP - 1741

JO - Journal of the American Chemical Society

JF - Journal of the American Chemical Society

IS - 5

ER -

Discovery of antibiotic (E)-3-(3-carboxyphenyl)-2-(4-cyanostyryl)quinazolin-4(3 H)-one

Abstract

Bibliographical note

Funding

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this